Back to News
Market Impact: 0.6

S&P 500 Losers: From Lululemon To MGM — What Went Wrong?

LULUKVUEJNJTDGSTZMGM
Economic DataMonetary PolicyInterest Rates & YieldsCorporate Guidance & OutlookCompany FundamentalsLegal & LitigationConsumer Demand & RetailMarket Technicals & Flows
S&P 500 Losers: From Lululemon To MGM — What Went Wrong?

The S&P 500 remained largely unchanged last week, slipping 0.12%, against a backdrop of softer labor market data—nonfarm payrolls rose just 22,000, and unemployment hit 4.3%—reinforcing expectations for a Federal Reserve interest rate cut. Despite the flat index, several prominent S&P 500 stocks experienced significant declines, including Lululemon (-17%) due to a guidance cut, Kenvue (-10%) on emerging Tylenol litigation concerns, and MGM Resorts (-8%) amid leadership changes and declining visitor numbers. These sharp individual stock movements were driven by a mix of earnings outlook revisions, regulatory risks, downgrades, and demand concerns, illustrating idiosyncratic pressures within a stable broader market.

Analysis

The S&P 500's marginal 0.12% decline for the week ending September 5 belies significant underlying pressures and stock-specific repricing. Weak macroeconomic data, including a nonfarm payroll increase of only 22,000 against a 75,000 forecast and a rise in unemployment to 4.3%, has solidified market expectations for a near-term Federal Reserve interest rate cut. However, this macro environment provided little support for several individual equities that faced severe, idiosyncratic headwinds. Lululemon (LULU) plunged 17% after cutting its full-year guidance, a move that overshadowed its quarterly earnings beat and signaled to investors that its robust 17% growth in China could not fully offset a 4% contraction in U.S. same-store sales. Similarly, consumer demand concerns drove Constellation Brands (STZ) down 8% on projections of lower fiscal 2026 results due to weakening beer sales. MGM Resorts (MGM) also fell 8%, hit by the dual impact of a COO departure and a seventh consecutive month of declining Las Vegas visitation, which was down 12% year-over-year in July. Beyond demand issues, event-driven risks catalyzed sell-offs in Kenvue (KVUE), which dropped 10% on potential litigation linking Tylenol (nearly 10% of sales) to autism, and TransDigm (TDG), which declined 9% following downgrades related to its aerospace aftermarket business. The valuation compressions are notable: LULU now trades at 1.8x trailing sales versus a 6.9x five-year average, while STZ and MGM are also well below their historical multiples, indicating a sharp re-rating based on forward-looking risks rather than past performance.